François Gouin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
François Gouin has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
- Dominique Heymann
Nantes Université, CNRS, UMR6286, US2B, Nantes, France
3 shared publications - Antoine Chalopin
Clinique chirurgicale orthopédique et traumatologique, centre hospitalier universitaire de Nantes, Hôtel-Dieu, 1, place Alexis-Ricordeau, 44093 Nantes cedex, France; Inserm UI957, LPRO, faculté de médecine de Nantes, rue Gaston-Veil, 44000 Nantes, France
2 shared publications - Françoise Rédini
INSERM UMR1238, PHY-OS, Bone Sarcomas and Remodeling of Calcified Tissues, Nantes University, 44000 Nantes, France
2 shared publications - Guillaume Anthony Odri
Service de Chirurgie Orthopédique et Traumatologique, Centre Hospitalier Universitaire d’Orléans, 45100 Orléans, France
2 shared publications - Kévin Brulefert
Clinique chirurgicale orthopédique et traumatologique, centre hospitalier universitaire de Nantes, Hôtel-Dieu, 1, place Alexis-Ricordeau, 44093 Nantes cedex, France; Inserm UI957, LPRO, faculté de médecine de Nantes, rue Gaston-Veil, 44000 Nantes, France
2 shared publications - Philippe Anract
Institut Curie, Paris, France; Cochin Hospital, Paris, France
2 shared publications
Latest Publications
- Open Access
- 20 May 2019
- Published by Springer Nature in Trials
- Vol. 20 (1) , 275
Improvement in staff behavior during surgical procedures to prevent post-operative complications (ARIBO2): study protocol for a cluster randomised trial
Inappropriate staff behaviour during surgical procedures may disrupt the surgical performance and compromise patient safety. We developed an innovative monitoring and feedback system combined with an adaptive approach to optimise staff behaviour intraoperatively and prevent post-operative complications (POC) in orthopaedic surgery. This protocol describes a parallel-group, cluster randomised, controlled trial with orthopaedic centre as the unit of randomisation. The intervention period will last 6 months and will be based on the monitoring of two surrogates of staff behaviour: the frequency of doors opening and the level of noise. Both will be collected from incision to wound closure, using wireless sensors and sonometers, and recorded and analysed on a dedicated platform (Livepulse®). Staff from centres randomised to the intervention arm will be informed in real time on their own data through an interactive dashboard available in each operating room (OR), and a posteriori for hip and knee replacement POC. Aggregated data from all centres will also be displayed for benchmarking. A lean method will be applied in each centre by a local multidisciplinary team to analyse baseline situations, determine the target condition, analyse the root cause(s), and take countermeasures. The education and awareness of participants on the impact of their behaviour on patient safety will assist the quality improvement process. The control centres will be blinded to monitoring data and quality improvement approaches. The primary outcome will be any POC occurring during the 30 days post operation. We will evaluate this outcome using local and national routinely collected data from hospital discharge and disease databases. Thirty orthopaedic centres will be randomised for a total of 9945 hip and knee replacement surgical procedures. The field of human factors and behaviour in the OR seems to offer potential room for improvement. An intervention providing goal-setting, monitoring, feedback and action planning may reduce the traffic flow and interruptions/distractions of the surgical team during procedures, preventing subsequent POCs. The results of this trial will provide important data on the impact of OR staff behaviour on patient safety, and promote best practice during surgical procedures. ClinicalTrials.gov, NCT03158181 .
- 20 May 2019
- Published by Springer Nature in Trials
- Vol. 20 (1) , 275
Open AccessImprovement in staff behavior during surgical procedures to prevent post-operative complications (ARIBO2): study protocol for a cluster randomised trial
Inappropriate staff behaviour during surgical procedures may disrupt the surgical performance and compromise patient safety. We developed an innovative monitoring and feedback system combined with an adaptive approach to optimise staff behaviour intraoperatively and prevent post-operative complications (POC) in orthopaedic surgery. This protocol describes a parallel-group, cluster randomised, controlled trial with orthopaedic centre as the unit of randomisation. The intervention period will last 6 months and will be based on the monitoring of two surrogates of staff behaviour: the frequency of doors opening and the level of noise. Both will be collected from incision to wound closure, using wireless sensors and sonometers, and recorded and analysed on a dedicated platform (Livepulse®). Staff from centres randomised to the intervention arm will be informed in real time on their own data through an interactive dashboard available in each operating room (OR), and a posteriori for hip and knee replacement POC. Aggregated data from all centres will also be displayed for benchmarking. A lean method will be applied in each centre by a local multidisciplinary team to analyse baseline situations, determine the target condition, analyse the root cause(s), and take countermeasures. The education and awareness of participants on the impact of their behaviour on patient safety will assist the quality improvement process. The control centres will be blinded to monitoring data and quality improvement approaches. The primary outcome will be any POC occurring during the 30 days post operation. We will evaluate this outcome using local and national routinely collected data from hospital discharge and disease databases. Thirty orthopaedic centres will be randomised for a total of 9945 hip and knee replacement surgical procedures. The field of human factors and behaviour in the OR seems to offer potential room for improvement. An intervention providing goal-setting, monitoring, feedback and action planning may reduce the traffic flow and interruptions/distractions of the surgical team during procedures, preventing subsequent POCs. The results of this trial will provide important data on the impact of OR staff behaviour on patient safety, and promote best practice during surgical procedures. ClinicalTrials.gov, NCT03158181 .
- Open Access
- 10 October 2018
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 15 (10) , 2204
Geographical Accessibility of the Sarcoma Referral Networks in France. Intermediate Results from the IGéAS Research Program
Rare cancer patients face lower survival and experience delays in diagnosis and therapeutic mismanagement. Considering the specificities of rare cancers, referral networks have been implemented in France to improve the management and survival of patients. The IGéAS research program aims to assess the networks’ ability to reduce inequalities. Data analysis of the IGéAS cohort (n = 20,590, sarcoma diagnosed between 2011 and 2014) by gathering medical data and geographical index will identify risk factors associated with the belated access to expertise or with no access to expertise. Intermediate results show that referral networks give sarcoma patients access to sarcoma expertise despite the remoteness of some of them. Regional expert centers mostly receive requests from within their area while national referral centers receive requests from the whole country. Delays in the access to expertise may be reduced by making outside practitioners more sensitive to the issues of rare cancers. The perception and involvement of outside practitioners in this device will be assessed using a qualitative survey. All the results are discussed and will contribute to design guidelines to improve early access to expertise and reduce inequalities. Results of the IGéAS research program may contribute to the assessment of referral sarcoma networks and provide some useful lessons to improve cancer care management.
- 10 October 2018
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 15 (10) , 2204
Open AccessGeographical Accessibility of the Sarcoma Referral Networks in France. Intermediate Results from the IGéAS Research Program
Rare cancer patients face lower survival and experience delays in diagnosis and therapeutic mismanagement. Considering the specificities of rare cancers, referral networks have been implemented in France to improve the management and survival of patients. The IGéAS research program aims to assess the networks’ ability to reduce inequalities. Data analysis of the IGéAS cohort (n = 20,590, sarcoma diagnosed between 2011 and 2014) by gathering medical data and geographical index will identify risk factors associated with the belated access to expertise or with no access to expertise. Intermediate results show that referral networks give sarcoma patients access to sarcoma expertise despite the remoteness of some of them. Regional expert centers mostly receive requests from within their area while national referral centers receive requests from the whole country. Delays in the access to expertise may be reduced by making outside practitioners more sensitive to the issues of rare cancers. The perception and involvement of outside practitioners in this device will be assessed using a qualitative survey. All the results are discussed and will contribute to design guidelines to improve early access to expertise and reduce inequalities. Results of the IGéAS research program may contribute to the assessment of referral sarcoma networks and provide some useful lessons to improve cancer care management.
- 1 May 2018
- Published by Elsevier in The Lancet Oncology
- Vol. 19 (5) , 584-586
Nilotinib in locally advanced pigmented villonodular synovitis: challenges of a new targeted therapy
- 1 May 2018
- Published by Elsevier in The Lancet Oncology
- Vol. 19 (5) , 584-586
Nilotinib in locally advanced pigmented villonodular synovitis: challenges of a new targeted therapy
- 1 February 2018
- Published by Elsevier in Bulletin du Cancer
- Vol. 105 (2) , 215
Erratum à l’article « Reconstruction après résection pour tumeur osseuse de l’épaule » [Bull. Cancer 101 (2014) 951–957]
- 1 February 2018
- Published by Elsevier in Bulletin du Cancer
- Vol. 105 (2) , 215
Erratum à l’article « Reconstruction après résection pour tumeur osseuse de l’épaule » [Bull. Cancer 101 (2014) 951–957]
- 1 September 2017
- Published by Elsevier in Orthopaedics & Traumatology: Surgery & Research
- Vol. 103 (5) , 809-814
Giant cell tumor of tendon sheath: Open surgery or arthroscopic synovectomy? A systematic review of the literature
- 1 September 2017
- Published by Elsevier in Orthopaedics & Traumatology: Surgery & Research
- Vol. 103 (5) , 809-814
Giant cell tumor of tendon sheath: Open surgery or arthroscopic synovectomy? A systematic review of the literature
- Top Cited Papers
- 1 February 2017
- Published by Elsevier in Orthopaedics & Traumatology: Surgery & Research
- Vol. 103 (1) , S91-S97
Localized and diffuse forms of tenosynovial giant cell tumor (formerly giant cell tumor of the tendon sheath and pigmented villonodular synovitis)
- 1 February 2017
- Published by Elsevier in Orthopaedics & Traumatology: Surgery & Research
- Vol. 103 (1) , S91-S97
Top Cited PapersLocalized and diffuse forms of tenosynovial giant cell tumor (formerly giant cell tumor of the tendon sheath and pigmented villonodular synovitis)
- 1 February 2017
- Published by Elsevier in Orthopaedics & Traumatology: Surgery & Research
- Vol. 103 (1) , 27-31
Subperitoneal approach in revision arthroplasty for acetabular component protrusion: Analysis of practices within the French Hip and Knee Society (SFHG)
- 1 February 2017
- Published by Elsevier in Orthopaedics & Traumatology: Surgery & Research
- Vol. 103 (1) , 27-31
Subperitoneal approach in revision arthroplasty for acetabular component protrusion: Analysis of practices within the French Hip and Knee Society (SFHG)
- 27 November 2015
- Published by Springer Nature in International Orthopaedics
- Vol. 40 (9) , 1843-1848
What are the risk factors for post-operative infection after hip hemiarthroplasty? Systematic review of literature
Femoral neck fractures are frequent in the elderly population and lead to high morbidity and mortality. Hemiarthroplasty is an established surgical procedure for displaced intracapsular femoral neck fractures. Post-operative infection is frequent and is potentially devastating for the patient and the healthcare services. The goal of this study was to identify the risk factors of infection after hemiarthroplasty and help adapt our surgical practice. A systematic review of the literature was performed in July 2015 by two authors using the MedLine, PubMed and Cochrane databases. We used the MeSH keywords “hip hemiarthroplasty” AND “infection” to identify risk factors and methods of prevention for surgical site infection after hemiarthroplasty. Following the search, two authors independently performed the first stage based on titles and abstracts. Thirty-seven articles were selected. Review and analysis of the references was performed to find other articles of interest. Thirteen articles were selected to analyse. According to literature, the surgical site infection (SSI) rate after hip hemiarthroplasty (HHA) is between 1.7 and 7.3 %. Pre-operative comorbidities (obesity, liver disease, advanced age), operative conditions (junior surgeon, uncemented stems, time of surgery) and post-operative management (length of hospitalisation, haematoma, prolonged wound drainage and two urinary catheterisations) were identified as risk factors of surgical site infection. Authors describe conditions to decrease the incidence of these complications and underline the importance of “a specialised hip team” that provides fast care and helps decrease the duration of hospitalisation. Careful patient management for hemiarthroplasty is vital and may decrease the incidence of surgical site infection, which is associated with high morbidity and high procedure cost. Our review suggests that there are specific correctable risk factors for SSIs after HHA. Being able to identify these risk factors leads to better care because of SSI prevention in patients undergoing HHAs after femoral neck fractures. To improve the outcomes, some methods of prevention of surgical site infection are available: before, during and after the operation. Review of literature. Level of evidence: IV
- 27 November 2015
- Published by Springer Nature in International Orthopaedics
- Vol. 40 (9) , 1843-1848
What are the risk factors for post-operative infection after hip hemiarthroplasty? Systematic review of literature
Femoral neck fractures are frequent in the elderly population and lead to high morbidity and mortality. Hemiarthroplasty is an established surgical procedure for displaced intracapsular femoral neck fractures. Post-operative infection is frequent and is potentially devastating for the patient and the healthcare services. The goal of this study was to identify the risk factors of infection after hemiarthroplasty and help adapt our surgical practice. A systematic review of the literature was performed in July 2015 by two authors using the MedLine, PubMed and Cochrane databases. We used the MeSH keywords “hip hemiarthroplasty” AND “infection” to identify risk factors and methods of prevention for surgical site infection after hemiarthroplasty. Following the search, two authors independently performed the first stage based on titles and abstracts. Thirty-seven articles were selected. Review and analysis of the references was performed to find other articles of interest. Thirteen articles were selected to analyse. According to literature, the surgical site infection (SSI) rate after hip hemiarthroplasty (HHA) is between 1.7 and 7.3 %. Pre-operative comorbidities (obesity, liver disease, advanced age), operative conditions (junior surgeon, uncemented stems, time of surgery) and post-operative management (length of hospitalisation, haematoma, prolonged wound drainage and two urinary catheterisations) were identified as risk factors of surgical site infection. Authors describe conditions to decrease the incidence of these complications and underline the importance of “a specialised hip team” that provides fast care and helps decrease the duration of hospitalisation. Careful patient management for hemiarthroplasty is vital and may decrease the incidence of surgical site infection, which is associated with high morbidity and high procedure cost. Our review suggests that there are specific correctable risk factors for SSIs after HHA. Being able to identify these risk factors leads to better care because of SSI prevention in patients undergoing HHAs after femoral neck fractures. To improve the outcomes, some methods of prevention of surgical site infection are available: before, during and after the operation. Review of literature. Level of evidence: IV
- 1 September 2014
- Published by Elsevier in European Journal of Cancer
- Vol. 50 (14) , 2425-2431
Adjuvant treatment with zoledronic acid after extensive curettage for giant cell tumours of bone
- 1 September 2014
- Published by Elsevier in European Journal of Cancer
- Vol. 50 (14) , 2425-2431
Adjuvant treatment with zoledronic acid after extensive curettage for giant cell tumours of bone
- 20 July 2014
- Published by Springer Nature in International Orthopaedics
- Vol. 38 (12) , 2447-2453
Acetabular reconstruction using a free fibular autograft in total hip arthroplasty revisions
Acetabular reconstruction for segmentary bone loss aims for primary stability and long-lasting integration. The use of a fibular autograft has been described after tumour resection and in traumatology. The hypothesis of this study is that it offers a mechanically reliable solution with good functional results and acceptable morbidity. This is a two center retrospective study of 26 operated hips. Indication was mechanical loosening in every case. The operative technique included fibular grafting of a segmental bone loss associated with an acetabular metal reinforcement. Mean follow up was 88 months (three to 165). The PMA score increased from 8.5 (five to 12) to 15 (six to 18) (p <0.001). Acetabular migration was 2 mm (0–4) vertically and 1 mm (0–2) medially. Three graft failures were observed. No major morbidity was observed. Fibular autograft after mechanical loosening and segmentary bone loss in total hip arthroplasty revisions offers a mechanically reliable solution for acetabular reconstruction. The results seem to be at least equivalent to other techniques.
- 20 July 2014
- Published by Springer Nature in International Orthopaedics
- Vol. 38 (12) , 2447-2453
Acetabular reconstruction using a free fibular autograft in total hip arthroplasty revisions
Acetabular reconstruction for segmentary bone loss aims for primary stability and long-lasting integration. The use of a fibular autograft has been described after tumour resection and in traumatology. The hypothesis of this study is that it offers a mechanically reliable solution with good functional results and acceptable morbidity. This is a two center retrospective study of 26 operated hips. Indication was mechanical loosening in every case. The operative technique included fibular grafting of a segmental bone loss associated with an acetabular metal reinforcement. Mean follow up was 88 months (three to 165). The PMA score increased from 8.5 (five to 12) to 15 (six to 18) (p <0.001). Acetabular migration was 2 mm (0–4) vertically and 1 mm (0–2) medially. Three graft failures were observed. No major morbidity was observed. Fibular autograft after mechanical loosening and segmentary bone loss in total hip arthroplasty revisions offers a mechanically reliable solution for acetabular reconstruction. The results seem to be at least equivalent to other techniques.